Alliance Healthcare Czech Republic made a net profit of CZK CZK 239 mil under revenues of CZK 20,974 mil in 2014, up 18.3% and 52.0%, respectively, when compared to the last year.
This translates into a net margin of 1.14%. Historically, the firm’s net margin reached an all time high of 1.47% in 2013 and an all time low of 0.708% in 2006. The average net margin in the last five years amounted to 1.24%.
On the operating level, EBITDA margin reached 1.57% and EBIT amounted to 1.77% of sales in 2014.
As far as Alliance Healthcare Czech Republic's peers are concerned, Bayer Czech Republic posted net and EBITDA margin of 2.64% and 3.53%, respectively in 2014, Amgen Czech Republic generated margins of 6.36% and 8.55% and Roche Czech Republic's profit margin reached 2.17% on the net and 6.07% on the EBITDA level in 2014.